DHEA-Neuroprotection and -Neurotoxicity after Transient Cerebral Ischemia in Rats
Open Access
- 15 October 2008
- journal article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 29 (2), 287-296
- https://doi.org/10.1038/jcbfm.2008.118
Abstract
Dehydroepiandrosterone (DHEA) has been implicated not only to prevent N-methyl-d-aspartate (NMDA)-induced neurotoxicity but also to enhance Ca2+ influx through NMDA receptor (NMDAr). However, these DHEA effects, which would produce inconsistent outcomes about neuronal damages, are not well studied in ischemia-induced cerebral damages. Herein, we report that a single administration of DHEA (20 mg/kg) during 3 to 48 h after transient global cerebral ischemia in rats exerted neuroprotective effects such as reduction of ischemia-induced neuronal death in the hippocampal CA1 and improvement of ischemia-induced deficits in spatial learning. By contrast, at 1 h before or after ischemia, the administration of DHEA exacerbated the ischemia-induced neuronal death and learning impairment. This DHEA neurotoxicity appeared to be caused by DHEA itself, but not through its metabolite testosterone, and was inhibited by a pretreatment with the NMDAr blocker MK801 or the sigma-1 (σ1) receptor antagonist NE100. However, the DHEA neuroprotection was blocked by NE100. These results show that DHEA not only provides robust ischemic neuroprotection with a long therapeutic opportunity but also exerts neurotoxicity when administered during ischemia and early reperfusion, which points to the importance of administration timing of DHEA in the clinical treatment of brain damages by the transient brain ischemia including stroke.Keywords
This publication has 43 references indexed in Scilit:
- Two different molecular mechanisms underlying progesterone neuroprotection against ischemic brain damageNeuropharmacology, 2008
- Ca 2+ Signals and Neuronal Death in Brain IschemiaStroke, 2007
- The anti‐amnesic and neuroprotective effects of donepezil against amyloid β25‐35 peptide‐induced toxicity in mice involve an interaction with the σ1 receptorBritish Journal of Pharmacology, 2006
- Down-regulation of the glial glutamate transporter GLT-1 in rat hippocampus and striatum and its modulation by a group III metabotropic glutamate receptor antagonist following transient global forebrain ischemiaNeuropharmacology, 2005
- Protein Kinase C-Dependent Potentiation of Intracellular Calcium Influx by σ1Receptor Agonists in Rat Hippocampal NeuronsJournal of Pharmacology and Experimental Therapeutics, 2003
- The Role of Atypical and Conventional PKC in Dehydroepiandrosterone-Induced Glucose Uptake and Dexamethasone-Induced Insulin ResistanceBiochemical and Biophysical Research Communications, 2000
- σ 1 -Receptor Ligand 4-Phenyl-1-(4-Phenylbutyl)-Piperidine Affords Neuroprotection From Focal Ischemia With Prolonged ReperfusionStroke, 2000
- PPBP [4-Phenyl-1-(4-phenylbutyl) Piperidine] Decreases Brain Injury After Transient Focal Ischemia in RatsStroke, 1996
- PPBP [4-Phenyl-1-(4-phenylbutyl) Piperidine], a Potent ς-Receptor Ligand, Decreases Brain Injury After Transient Focal Ischemia in CatsStroke, 1995
- Origin of intracellular Ca2+ elevation induced by in vitro ischemia-like condition in hippocampal slicesBrain Research, 1993